Senior International Medical Digital Manager

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
As Senior International Digital Medical Manager you will accelerate the adoption of digital within the specific Medical Therapeutic Area and live your passion of thinking outside of the box. You will be part of a dynamic team where you will have the opportunity to use your creative skills and digital mindset to provide a unique Boehringer Ingelheim customer experience.

Tasks & responsibilities

  • As Senior International Medical Digital Manager you create a plan to catalyse the medical digital transformation within the Therapeutic Area (TA) Oncology at Boehringer Ingelheim.
  • You will align with the Digital Manager and the Medical Affairs brand lead in order to ensure an optimal customer journey which is aligned with our brand and customer plans.
  • Furthermore, you will co-create the TA content to be innovative, cutting-edge and strategic as well as desirable and usable for the local country implementation, for example multi-channel content, videos, infographics and webinars.
  • In your new role you set key performance indicators to ensure measurability and the track user journey.
  • Last but not least you identify innovations that can evolve or transform the TA customer experience within the complex regulatory environment.

Requirements

  • Registered Medical Practitioner, Master of Science or PhD; experience in Therapeutic Areas/Oncology preferred
  • A minimum of 5 years of work experience regarding the following:
    • Significant medical experience within healthcare
    • Effective digital mindset to innovate, create the strategy and fully execute
    • Ability to implement new digital opportunities
    • Substantial experience in mix of local and international roles
    • Experience in a matrix organization and in cross-functional teams
  • Fluent English both written and spoken, German would be a plus

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best eHealth talent! For further information, please contact us.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...